期刊文献+

河南省维持性血液透析患者心血管并发症调查分析 被引量:7

Investigation and analysis of cardiovascular complications in maintenance hemodialysis patients in Henan province
下载PDF
导出
摘要 目的调查分析河南省维持性血液透析(maintenance hemodialysis,MHD)患者心血管并发症的患病情况及相关因素。方法选择2006年9月~2007年12月河南省17个地市MHD患者共3278例,调查分析以下参数:①一般资料和血液透析参数;②心血管并发症:包括左心室肥厚,心肌缺血,充血性心力衰竭等患病情况;③相关因素调查:主要统计肾性贫血、高血压、透析不充分发生率。结果①心血管并发症:左心室肥厚占61.19%,心电图缺血性S-T段改变39.80%,充血性心力衰竭为29.59%,心律失常22.58%,冠状动脉疾病的患病率为18.41%,心包积液17.52%;②相关因素分析:肾性贫血、高血压、透析不充分患者心血管并发症患病率均明显高于无贫血、血压正常及透析充分者,差异性具有统计学意义。结论河南省MHD患者心血管并发症患病率较高,肾性贫血、高血压、透析不充分是影响心血管并发症发生发展的重要因素,积极防治心血管并发症及其相关因素,是提高MHD患者生活质量的关键所在。 Objective To investigate and analyze the morbidity rates and factors relating to cardiovascular complications in maintenance hemodialysis patients in Henan province. Methods We collected 3278 main- tenance hemodialysis patients from 17 cities in Henan province within the period from June 2006 to December 2007. We investigated and analyzed their general clinical data and hemodialysis parameters, the incidence of cardiovascular complications including left ventricular hypertrophy, heart muscle ischemia and congestive heart failure, and the factors possibly relating to cardiovascular complications including renal anemia, hypertension and insufficient dialysis, Results In these patients, the incidence of left ventricular hypertrophy was 61.19%, and that of heart muscle ischemia 39.80%, congestive heart failure 29.59%, arrhythmia 22.58%, coronary artery disease 18.41%, and hydropericardium 17.52%. The incidence of cardiovascular complications was significantly higher in patients with renal anemia, hypertension and insufficient dialysis than those without anemia and hypertension and with adequate dialysis, Conclusion The morbidity rate of cardiovascular complications was high in maintenance hemodialysis patients in Henan province. Renal anemia, hypertension and insufficient dialysis were the important risk factors for the complication of cardiovascular diseases. Therefore, prevention and management of cardiovascular complications and their related factors are important measures in improving their living quality.
出处 《中国血液净化》 2008年第7期361-362,365,共3页 Chinese Journal of Blood Purification
关键词 血液透析 心血管并发症 相关因素 Hemodialysis Cardiovascular complications Correlated factors
  • 相关文献

参考文献9

  • 1Cheung AK, Sarnak MJ, Yan S, et al. Cardiac disease in maintenance hemodialysis Patients:Results of the HEMO study [J]. Kjdney Int, 2004,65:2380-2389. 被引量:1
  • 2US Renal Data System. 1999 Annual Data Report[J]. Am J Kidney Dis, 1999, 34[supplel]. 被引量:1
  • 3叶任高主编.内科学(第五版)[M].人民卫生出版社,2002.294-307,155-171,172-211,280-312,355-357. 被引量:1
  • 4NKF-DOQI. Clinical practice guidelines: Treatment of anemia of chronic renal failure [J]. Am J Kidney D is, 2001, 37(Suppl 1) : S182- S238. 被引量:1
  • 5Daugridas JT:Second generation logarithm estimates of Single-pool variable volume KT/V: An analysis of error. Soc Nephrol, 1993,4:1205-1213. 被引量:1
  • 6侯凡凡,马志刚,梅长林,戎殳,黄颂敏,刘先蓉,袁伟杰,郭云珊,王莉,何强,王秀玲,桑晓红,栗霄立.中国五省市自治区慢性肾脏病患者心血管疾病的患病率调查[J].中华医学杂志,2005,85(7):458-463. 被引量:182
  • 7上海市肾脏病心血管并发症调查协作组,陈楠,俞海瑾.上海地区慢性肾功能衰竭患者心血管并发症的调查[J].中华肾脏病杂志,2001,17(2):91-94. 被引量:63
  • 8Madhumathi Rao, Brian. J.G. Pereira:Prospective trials on anemia of chronic disease:The trial to reduce cardiovascular events with Aranesp therapy{J]. Kidney Int, 2003,64 (Suppl 87):S12-S19. 被引量:1
  • 9Carmine Z. Cardiovascular risk in uraemic patients is it fully explained by classical risk factors[J].Nephrol Dial Transplant, 2000,15:454-457. 被引量:1

二级参考文献18

  • 1侯凡凡.慢性肾脏病的心血管并发症[J].中华心血管病杂志,2004,32:16-16. 被引量:11
  • 2何长民 张训 见:何长民 张训主编.前言[A].见:何长民,张训主编.肾脏替代治疗学[C].上海:上海科学技术文献出版社,1999.2.. 被引量:1
  • 3Locatelli F, Pozzoni P, Tentori F, et al. Epidemiology of cardiovascular risk in patients with chronic kidney disease. Nephrol Dial Transplant, 2003,18 Suppl 7:2-9. 被引量:1
  • 4Muntner P, He J, Hamm L, et al. Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. J Am Soc Nephrol, 2002,13:745-753. 被引量:1
  • 5Manjunath G, Tighiouart H, Ibrahim H, et al. Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community. J Am Coll Cardiol, 2003,41:47-55. 被引量:1
  • 6Foley RN, Parfrey PS, Harnett JD, et al. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int, 1995,47:186-192. 被引量:1
  • 7Sarnak MJ, Levey AS, Schoolwerth AC,et al. Kidney disease as a risk factor for development of cardiovascular disease. A statement from the American Heart Association Councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention. Circulation, 2003,108:2154-2169. 被引量:1
  • 8Foley RN, Herzog CA, Collins AJ. Smoking and cardiovascular outcomes in dialysis patients: the United States Renal Data System Wave 2 Study. Kidney Int, 2003,63:1462-1467. 被引量:1
  • 9Wong JS, Rort FK, Hulbert-Shearon TE, et al. Survival advantage in Asian American end-stage renal disease patients. Kidney Int, 1999,55:2515-2523. 被引量:1
  • 10Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis, 1998,32:s112-s119. 被引量:1

共引文献233

同被引文献71

引证文献7

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部